Company Filing History:
Years Active: 2017-2019
Title: Innovator Cristina Maria Eiroa Martinez: Pioneering Cannabidiol Tablets for Mental Health Treatment
Introduction
Cristina Maria Eiroa Martinez, a talented inventor based in Amsterdam, NL, has made significant contributions to the field of pharmaceuticals with her innovative work on compressed tablets containing cannabidiol (CBD). With a total of three patents to her name, she is at the forefront of research aimed at improving oral treatment options for individuals suffering from psychosis and anxiety disorders.
Latest Patents
Cristina's latest patent addresses the formulation and manufacturing methods of compressed tablets designed for the effective delivery of cannabidiol. Specifically, the invention details a compressed tablet weighing between 60-1200 mg, composed of a specific ratio of granulate, lactose, and other excipients. The granulate itself includes 2-15 wt. % of cannabidiol, along with other components that enhance the tablet's efficacy and usability. This innovation provides a new, convenient option for patients experiencing psychosis disorders or anxiety disorders, thereby expanding treatment opportunities in a growing area of mental health care.
Career Highlights
Currently employed by Echo Pharmaceuticals B.V., Cristina has established herself as a key figure in pharmaceutical innovation. Her expertise in the development of cannabinoid-based treatments positions her as a leader in the sector. With her strong foundation in research and development, she continues to push the boundaries of what's possible in medication formulation.
Collaborations
Cristina collaborates closely with her colleagues, Jan Albert De Vries and Maria Vanesa Fernandez Cid, at Echo Pharmaceuticals B.V. Together, they share a commitment to advancing research that positively impacts mental health treatments. Their combined efforts contribute to a creative and innovative work environment focused on addressing important health challenges.
Conclusion
Cristina Maria Eiroa Martinez is a remarkable inventor in the realm of pharmaceuticals, particularly noted for her groundbreaking work with cannabidiol tablets. As she continues to develop new therapies aimed at alleviating mental health disorders, her contributions are set to pave the way for more effective treatments in this vital area of healthcare. Her work exemplifies the crucial role of innovation in addressing complex medical issues.